American Heart Journal
Volume 147, Issue 6 , Pages 942-944 , June 2004

Is there something special about ischemic heart disease in patients undergoing dialysis?

  • Charles A Herzog, MD

      Affiliations

    • Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis, Minn, USA
    • Corresponding Author InformationReprint requests: Charles A. Herzog, MD, Hennepin County Medical Center, Department of Medicine, 701 Park Ave—Mail Code 865A, Minneapolis, MN 55415-1829, USA.

References 

  1. US Renal Data System. USRDS 2002 annual data report. Bethesda (Md): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2002
  2. US Renal Data System. USRDS 2003 annual data report. Bethesda (Md); National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2003
  3. Luke RG. Chronic renal failure—a vasculopathic state. N Engl J Med. 1998;339:841–843
  4. Blacher J, Guerin AP, Pannier B, et al.  Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434–2439
  5. Goodman WG, Goldin J, Kuizon BD, et al.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478–1483
  6. Oh J, Wunsch R, Turzer M, et al.  Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106:100–105
  7. Miyazaki H, Matsuoka H, Itabe H, et al.  Hemodialysis impairs endothelial function via oxidative stress (effects of vitamin E-coated dialyzer). Circulation. 2000;101:1002–1006
  8. Di Carli MF, Janisse J, Grunberger G, et al.  Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003;41:1387–1393
  9. Kasiske BL, Cangro CB, Hariharan S, et al.  The evaluation of renal transplantation candidates (clinical practice guidelines). Am J Transplantation. 2002;1(Suppl 2):1–95
  10. Gaston RS, Danovitch GM, Adams PL, et al.  The report of a national conference on the wait list for kidney transplantation. Am J Transplantation. 2003;3:775–785
  11. Manske CL, Wang Y, Rector T, et al.  Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet. 1992;340:998–1002
  12. Herzog CA, Marwick TH, Pheley AM, et al.  Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis. 1999;33:1080–1090
  13. Rabbat CG, Treleaven DJ, Russell JD, et al.  Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation (a meta-analysis). J Am Soc Nephrol. 2003;14:431–439
  14. Marwick TH, Steinmuller DR, Underwood DA, et al.  Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation. 1990;49:100–103
  15. Boudreau RJ, Strony JT, duCret RP, et al.  Perfusion thallium imaging of type I diabetes patients with end stage renal disease (comparison of oral and intravenous dipyridamole administration). Radiology. 1990;175:103–105
  16. Vandenberg BF, Rossen JD, Grover-McKay M, et al.  Evaluation of diabetic patients for renal and pancreas transplantation (noninvasive screening for coronary artery disease using radionuclide methods). Transplantation. 1996;62:1230–1235
  17. Dahan M, Viron BM, Faraggi M, et al.  Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int. 1998;54:255–262

PII: S0002-8703(04)00018-3

doi: 10.1016/j.ahj.2003.12.025

American Heart Journal
Volume 147, Issue 6 , Pages 942-944 , June 2004

Article Tools